• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC MYOSURE REACH TISSUE REMOVAL DEVICE; HYSTEROSCOPE (AND ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC MYOSURE REACH TISSUE REMOVAL DEVICE; HYSTEROSCOPE (AND ACCESSORIES) Back to Search Results
Model Number 10-401FC
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); Uterine Perforation (2121)
Date of Event 06/25/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Lot number of the device not provided by the complainant; therefore, the udi, expiration and manufacturing dates are not known.Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.The device involved in this event was not returned for evaluation purposes therefore visual and functional analysis of the product could not be performed.We are unable to confirm a relationship between the device and the issue reported.The information obtained during complaint investigation will be included in our global complaint trending and product surveillance will continue to monitor complaints of this type for adverse trends.If the product is received or additional information is obtained, the investigation will be reopened accordingly per standard operating procedure.
 
Event or Problem Description
It was reported that a patient underwent a myosure and sonata procedure on (b)(6) 2026.The procedure was initiated using a myosure device for a 8cm fibroid.Due to the fibroid being calcified it was difficult to resect.The physician then used the sonata device to soften the fibroid.The physician then returned to using the myosure device to start resecting the remainder of the fibroid, when it was noted that the physician resected the posterior wall of the uterus.The physician then chose to perform laparoscopy and confirmed the uterine perforation.It was confirmed that there is no injury to the rectum.The physician then sutured the uterine perforation.The patient was admitted overnight for observation.Later that evening, the patient presented to the emergency department with pain.A computed tomography (ct) scan was performed and was unremarkable.Two laboratory studies showed the patient was nontoxic.Pain subsided and the patient was discharged.The patient will be going back to the hospital for another laparoscopic procedure for follow up the week of (b)(6) 2026.Additional information was received that the patient presented with pain and low grade fever the following day and the pathology report confirmed that there was a full thickness bowel tissue present in the sample.Patient was admitted to the operating room to find the defect and no additional information was received.No other information available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOSURE REACH TISSUE REMOVAL DEVICE
Common Device Name
HYSTEROSCOPE (AND ACCESSORIES)
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer (Section G)
HOLOGIC, INC.
250 campus drive
marlborough MA 01752
Manufacturer Contact
simran keswani
250 campus drive
marlborough, MA 01752
MDR Report Key25763605
Report Number1222780-2026-00434
Device Sequence Number13208464
Product Code HIH
UDI-Device Identifier15420045504530
UDI-Public15420045504530
Combination Product (Y/N)N
Initial Reporter StateSC
Initial Reporter CountryUS
PMA/510(K) Number
K152723
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 07/10/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number10-401FC
Device Catalogue Number10-401FC
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/29/2026
Supplement Date Received by Manufacturer07/10/2026
Initial Report FDA Received Date07/09/2026
Supplement Report FDA Received Date07/10/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention; Other;
Patient SexUnknown
-
-